Relationship-centred care (RCC) recognises that healthcare quality depends not only on outcomes, but on how voice, responsibility, and emotional labour are negotiated among patients, caregivers, and providers. As AI systems enter sensitive care contexts, they introduce a new participant into these negotiations. Drawing on empirical work in Advance Care Planning (ACP) and peer support, we argue that AI's primary impact in high-subjectivity domains is not optimisation but redistribution: it reorganises who speaks, who decides, and who bears moral responsibility. Across both settings, participants were less concerned with technical accuracy than with relational consequences: whether AI would appropriately represent their decision, reduce burden, or blur accountability, scaffold connection, or subtly displace it. We identify three relational dimensions: authority, temporality, and visibility, through which AI reshapes care relationships, and propose design provocations centred on relational legibility, bounded agency, responsibility traceability, and non-substitutive scaffolding.
Chronic illnesses are a global concern with essential hypertension and diabetes mellitus among the most common conditions. Remote patient monitoring has shown promising results on clinical and health outcomes. However, access to care and digital health solutions is limited among rural, lower-income, and older adult populations. This paper repots on a pre-post study of a comprehensive care coordination program including connected, wearable blood pressure and glucometer devices, tablets, and medical assistant-provided health coaching in a community health center in rural California. The participants (n=221) had a mean age of 54.6 years, were majority female, two-thirds spoke Spanish, 19.9% had hypertension, 49.8% diabetic, and 30.3% both conditions. Participants with hypertension achieved a mean reduction in systolic blood pressure of 20.24 (95% CI: 13.61, 26.87) at six months while those with diabetes achieved a mean reduction of 3.85 points (95% CI: 3.73, 4.88). These outcomes compare favorably to the small but growing body of evidence supporting digital care coordination and remote monitoring. These results also support the feasibility of well-designed digital health solutions yie
Demand for health care is constantly increasing due to the ongoing demographic change, while at the same time health service providers face difficulties in finding skilled personnel. This creates pressure on health care systems around the world, such that the efficient, nationwide provision of primary health care has become one of society's greatest challenges. Due to the complexity of health care systems, unforeseen future events, and a frequent lack of data, analyzing and optimizing the performance of health care systems means tackling a wicked problem. To support this task for primary care, this paper introduces the hybrid agent-based simulation model SiM-Care. SiM-Care models the interactions of patients and primary care physicians on an individual level. By tracking agent interactions, it enables modelers to assess multiple key indicators such as patient waiting times and physician utilization. Based on these indicators, primary care systems can be assessed and compared. Moreover, changes in the infrastructure, patient behavior, and service design can be directly evaluated. To showcase the opportunities offered by SiM-Care and aid model validation, we present a case study for
Social media based digital epidemiology has the potential to support faster response and deeper understanding of public health related threats. This study proposes a new framework to analyze unstructured health related textual data via Twitter users' post (tweets) to characterize the negative health sentiments and non-health related concerns in relations to the corpus of negative sentiments, regarding Diet Diabetes Exercise, and Obesity (DDEO). Through the collection of 6 million Tweets for one month, this study identified the prominent topics of users as it relates to the negative sentiments. Our proposed framework uses two text mining methods, sentiment analysis and topic modeling, to discover negative topics. The negative sentiments of Twitter users support the literature narratives and the many morbidity issues that are associated with DDEO and the linkage between obesity and diabetes. The framework offers a potential method to understand the publics' opinions and sentiments regarding DDEO. More importantly, this research provides new opportunities for computational social scientists, medical experts, and public health professionals to collectively address DDEO-related issues.
Generative AI systems are increasingly used by patients seeking everyday health guidance, yet their appropriateness in chronic care contexts remains unclear. Focusing on Type 2 Diabetes Mellitus (T2DM), this paper presents a mixed-methods investigation into how AI-generated health information is interpreted by patients and evaluated by physicians in China. Drawing on formative patient grounding and a dimension-based physician evaluation, we examine AI responses along five quality dimensions: Accuracy, Safety, Clarity, Integrity, and Action Orientation. Our findings reveal that while current systems perform well in factual explanation and general lifestyle guidance, they frequently break down in safety signaling, contextual judgment, and responsibility boundaries, particularly when fluent responses invite overtrust. By treating quality dimensions as an interpretive lens rather than a fixed framework, this work highlights the need for intelligent user interfaces that actively mediate AI outputs in chronic disease management, supporting calibrated trust and responsible boundary-setting in long-term care.
Social disadvantage is associated with multimorbidity, but the pathways linking social conditions to disease burden remain poorly understood. We developed an AI-driven multimodal mediation framework that integrates socioeconomic, psychosocial, clinical, laboratory, behavioral, and genomic data from the All of Us Research Program. Modality-specific variational autoencoders were used to derive latent representations of each data domain, and mediation analyses were subsequently performed in latent space to evaluate indirect associations between socioeconomic disadvantage, psychosocial factors, and multimorbidity. The final analytic cohort included 20,804 participants with complete multimodal data. Across 800 exposure--mediator--outcome combinations, mediation signals were concentrated within a small number of latent dimensions. The strongest indirect association linked a socioeconomic disadvantage dimension, a psychosocial vulnerability dimension, and a cardiometabolic multimorbidity dimension (NIE = 0.002517). The psychosocial dimension was characterized by poorer mental health, greater loneliness, lower social well-being, and lower health literacy, whereas the outcome dimension was
Social media provide a platform for users to express their opinions and share information. Understanding public health opinions on social media, such as Twitter, offers a unique approach to characterizing common health issues such as diabetes, diet, exercise, and obesity (DDEO), however, collecting and analyzing a large scale conversational public health data set is a challenging research task. The goal of this research is to analyze the characteristics of the general public's opinions in regard to diabetes, diet, exercise and obesity (DDEO) as expressed on Twitter. A multi-component semantic and linguistic framework was developed to collect Twitter data, discover topics of interest about DDEO, and analyze the topics. From the extracted 4.5 million tweets, 8% of tweets discussed diabetes, 23.7% diet, 16.6% exercise, and 51.7% obesity. The strongest correlation among the topics was determined between exercise and obesity. Other notable correlations were: diabetes and obesity, and diet and obesity DDEO terms were also identified as subtopics of each of the DDEO topics. The frequent subtopics discussed along with Diabetes, excluding the DDEO terms themselves, were blood pressure, hear
CARE-link is an open-source, web-based clinical support platform designed to improve the management of gestational diabetes by linking clinicians and patients through an LLM-mediated workflow. The system aggregates patient-generated data outside the hospital, summarizes relevant clinical information, and delivers context-aware decision support to clinicians. For patients, CARE-link provides clear explanations of management plans and delivers timely lifestyle guidance through a WhatsApp interface. The integrated dual-facing design aims to promote continuous monitoring, support individualized care, and reduce the burden of in-clinic follow-ups. Built with a modular architecture, the platform can be adapted to other chronic conditions requiring longitudinal tracking and behavioral support. CARE-link has the potential to enhance clinical oversight, promote patient compliance, and strengthen continuity of care particularly in resource-constrained settings.
Diabetes is a chronic disease with a significant global health burden, requiring multi-stakeholder collaboration for optimal management. Large language models (LLMs) have shown promise in various healthcare scenarios, but their effectiveness across diverse diabetes tasks remains unproven. Our study introduced a framework to train and validate diabetes-specific LLMs. We first developed a comprehensive data processing pipeline that includes data collection, filtering, augmentation and refinement. This created a high-quality, diabetes-specific dataset and evaluation benchmarks from scratch. Fine-tuned on the collected training dataset, our diabetes-specific LLM family demonstrated state-of-the-art proficiency in processing various diabetes tasks compared to other LLMs. Furthermore, clinical studies revealed the potential applications of our models in diabetes care, including providing personalized healthcare, assisting medical education, and streamlining clinical tasks. Generally, our introduced framework helps develop diabetes-specific LLMs and highlights their potential to enhance clinical practice and provide personalized, data-driven support for diabetes management across differen
We find ourselves on the ever-shifting cusp of an AI revolution -- with potentially metamorphic implications for the future practice of healthcare. For many, such innovations cannot come quickly enough; as healthcare systems worldwide struggle to keep up with the ever-changing needs of our populations. And yet, the potential of AI tools and systems to shape healthcare is as often approached with great trepidation as celebrated by health professionals and patients alike. These fears alight not only in the form of privacy and security concerns but for the potential of AI tools to reduce patients to datapoints and professionals to aggregators -- to make healthcare, in short, less caring. This infixated concern, we - as designers, developers and researchers of AI systems - believe it essential we tackle head on; if we are not only to overcome the AI implementation gap, but realise the potential of AI systems to truly augment human-centred practices of care. This, we argue we might yet achieve by realising newly-accessible practices of AI healthcare innovation, engaging providers, recipients and affected communities of care in the inclusive design of AI tools we may yet enthusiastically
Chronic disease management relies on regular patient-provider interactions to follow-up on disease progression and control. For Type 2 Diabetes (T2D), current guidelines prescribe fixed time intervals between subsequent primary care visits for all patients, overlooking heterogeneity in clinical trajectories and patient characteristics. This study introduces a Contextual Markov Decision Process (CMDP) model to optimize subpopulation-specific follow-up interval decisions using Electronic Health Record (EHR) data from 22,154 T2D patients across 10 primary care clinics. Contexts are identified by: i) dimensionality reduction of variables representing the individual health trajectories utilizing Principal Component Analysis, and ii) assigning patients to contexts via principal components and additional patient-level features using clustering. Two distinct contexts emerged, representing a lower- and a higher-risk subpopulation. CMDP-derived policies recommend: (i) follow-up within 1 month if lab value at current visit is unmeasured; (ii) up to 3 months for elevated lab values or recent hospitalizations; and (iii) 6 to 12 months for sustained glycemic control, with shorter follow-up inter
This review underscores the vital role of interoperability in digital health, advocating for a standardized framework. It focuses on implementing a Fast Healthcare Interoperability Resources (FHIR) server, addressing technical, semantic, and process challenges. FHIR's adaptability ensures uniformity within Primary Care Health Information Systems, fostering interoperability. Patient data management complexities highlight the pivotal role of semantic interoperability in seamless patient care. FHIR standards enhance these efforts, offering multiple pathways for data search. The ADR-guided FHIR server implementation systematically addresses challenges related to patient identity, biometrics, and data security. The detailed development phases emphasize architecture, API integration, and security. The concluding stages incorporate forward-looking approaches, including HHIMS Synthetic Dataset testing. Envisioning FHIR integration as transformative, it anticipates a responsive healthcare environment aligned with the evolving digital health landscape, ensuring comprehensive, dynamic, and interconnected systems for efficient data exchange and access.
Background: Diabetes is associated with obesity, poor glucose control and sleep dysfunction which impair cognitive and psychomotor functions, and, in turn, increase driver risk. How this risk plays out in the real-world driving settings is terra incognita. Addressing this knowledge gap requires comprehensive observations of diabetes driver behavior and physiology in challenging settings where crashes are more likely to occur, such as stop-controlled traffic intersections, as in the current study of drivers with Type 1 Diabetes (T1DM). Methods: 32 active drivers from around Omaha, NE participated in 4-week, real-world study. Each participant's own vehicle was instrumented with an advanced telematics and camera system collecting driving sensor data and video. Videos were analyzed using computer vision models detecting traffic elements to identify stop signs. Stop sign detections and driver stopping trajectories were clustered to geolocate and extract driver-visited stop intersections. Driver videos were then annotated to record stopping behavior and key traffic characteristics. Stops were categorized as safe or unsafe based on traffic law. Results: Mixed effects logistic regression m
Metabolic diseases such as type 2 diabetes and obesity represent a rapidly escalating global health burden, yet current therapeutic strategies largely target isolated symptoms or single molecular pathways. To this end, we developed an integrated computational pipeline leveraging knowledge graph, pathway analysis and network pharmacology to elucidate the multi-target mechanisms of Ayurvedic Single Herbal Drugs (SHDs). SHDs associated with diabetes and obesity were curated from the Ayurvedic Pharmacopoeia of India, followed by phytochemical identification using IMPPAT database, yielding a shortlist of 11 SHDs and their 188 phytochemicals after drug-likeness and bioavailability filtering. Subsequently, molecular targets of the phytochemicals in SHDs, disease-associated genes and therapeutic targets of FDA-approved drugs, were curated via integration of data from several databases. Pathway enrichment analysis revealed significant functional overlap between SHD-associated and disease-associated pathways. All curated data were embedded into a Neo4j-based knowledge graph, enabling SHD-disease intersection analysis that prioritized key disease-relevant targets, including PTPN1, GLP1R, and
Digital Twin (DT) technology has emerged as a transformative approach in healthcare, but its application in personalized patient care remains limited. This paper aims to present a practical implementation of DT in the management of chronic diseases. We introduce a general DT framework for personalized care planning (DT4PCP), with the core components being a real-time virtual representation of a patient's health and emerging predictive models to enable adaptive, personalized care. We implemented the DT4PCP framework for managing Type 2 Diabetes (DT4PCP-T2D), enabling real-time collection of behavioral data from patients with T2D, predicting emergency department (ED) risks, simulating the effects of different interventions, and personalizing care strategies to reduce ED visits. The DT4PCP-T2D also integrates social determinants of health (SDoH) and other contextual data, offering a comprehensive view of the patient's health to ensure that care recommendations are tailored to individual needs. Through retrospective simulations, we demonstrate that integrating DTs in T2D management can lead to significant advancements in personalized medicine. This study underscores the potential of DT
High-throughput experimentation can evaluate many reaction conditions, yet combinatorial condition spaces still exceed the available experiment budget. This makes experiment selection a sequential decision problem: each new condition must be chosen from limited observations before its outcome is known. LLMs can express task-specific selection logic. A direct recommendation, however, is neither a persistent executable object that can be validated and revised nor an independently auditable decision rule. We introduce CARE, a reference-conditioned controller that separates program synthesis from experiment selection. An LLM writes an executable scoring program that ranks the remaining conditions, while a non-LLM reference policy supplies a numerical candidate and support summary. CARE forms an optional alternative from the program, applies a reference-conditioned intervention gate to compare it with the reference, and records the decision before the selected outcome is revealed. Each new outcome updates controller state and can trigger retention, revision, or regeneration of the active program. This outcome-guided program evolution changes the scoring logic without updating the LLM pa
Purpose: Although elevated BMI is a well-known risk factor for type 2 diabetes, the disease's presence in some lean adults and absence in others with obesity suggests that detailed body composition may uncover abdominal phenotypes of type 2 diabetes. With AI, we can now extract detailed measurements of size, shape, and fat content from abdominal structures in 3D clinical imaging at scale. This creates an opportunity to empirically define body composition signatures linked to type 2 diabetes risk and protection using large-scale clinical data. Approach: To uncover BMI-specific diabetic abdominal patterns from clinical CT, we applied our design four times: once on the full cohort (n = 1,728) and once on lean (n = 497), overweight (n = 611), and obese (n = 620) subgroups separately. Briefly, our experimental design transforms abdominal scans into collections of explainable measurements through segmentation, classifies type 2 diabetes through a cross-validated random forest, measures how features contribute to model-estimated risk or protection through SHAP analysis, groups scans by shared model decision patterns (clustering from SHAP) and links back to anatomical differences (classifi
This review explores the synthesis, characterization, and therapeutic applications of zinc oxide nanoparticles (ZnO NPs) in the treatment of diabetes mellitus. The study delves into both chemical and green synthesis methods, comparing their impacts on nanoparticle properties. Key characterization techniques such as XRD, FTIR, UV-Vis spectroscopy, and SEM confirm the crystalline structure, optical properties, and morphology of the nanoparticles. ZnO NPs demonstrate significant biological activities, including antibacterial, anti-inflammatory, and antidiabetic effects. These nanoparticles show promise in improving glucose regulation, enhancing insulin sensitivity, and boosting glucose uptake in cells. Despite these benefits, the potential toxicity and long-term effects of ZnO NPs warrant further investigation. Future research should focus on optimizing synthesis methods and conducting comprehensive studies to fully exploit ZnO NPs' potential in diabetes management and other biomedical applications.
Relationship-centered care relies on trust and meaningful connection. As AI enters clinical settings, we must ask not just what it can do, but how it should be positioned to support these values. We examine a "middle, not top" approach where AI mediates communication without usurping human judgment. Through studies of CLEAR, an asynchronous messaging system, we show how this configuration addresses real-world constraints like time pressure and uneven health literacy. We find that mediator affordances (e.g., availability, neutrality) redistribute interpretive work and reduce relational friction. Ultimately, we frame AI mediation as relational infrastructure, highlighting critical design tensions around framing power and privacy.
From a public health perspective, previous research on comorbidity tends to have focused on identifying the most prevalent groupings of illnesses that demonstrate comorbidity, particularly among the elderly population, already in receipt of care. In contrast, little attention has been paid to possible socio-economic factors associated with increased rates of comorbidity or to the possibility of wider unrevealed need. Given the known relationship between CVD, diabetes and obesity and the strong socio-economic gradients in risk factors for each of the three diseases as single morbidities, this paper uses the Health Survey for England to examine the demographic and socio-economic determinants of each of the seven disease combinations in the English population. Using a multinomial logistic model, this research finds that gender is a significant predictor for all seven disease combinations. However, gender was not as influential as individual age or socio-economic profile. With regard to ethnicity, the black population presents a high obesity, diabetes and diabetes-related comorbidity risk, whilst the Asian population presents a high risk for diabetes and diabetes-related comorbidity bu